B F Farber. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cost-Benefit AnalysisCross Infection/economicsCross Infection/prevention & controlDiagnosis-Related GroupsHumansMedicare/economicsProspective Payment SystemReimbursement MechanismsUnited States
Year: 1984 PMID: 6436186 DOI: 10.1017/s0195941700060689
Source DB: PubMed Journal: Infect Control ISSN: 0195-9417